Research graph
References from Effects of Sub-Inhibitory Rifampicin, Minocycline, and Dalbavancin on Early Biofilm Formation and Transcriptional Responses in Staphylococcus aureus SA113. Local targets link to admitted publications; unresolved targets remain external evidence.
Early onset prosthetic hip and knee joint infection: Treatment and outcomes in Victoria, Australia
10.1016/j.jhin.2012.09.005 · 2012 · External reference
Management and Outcome of Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infections
10.1016/j.jacc.2007.01.072 · 2007 · External reference
Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management
10.1128/cmr.00134-14 · 2015 · External reference
Bacterial Biofilms: A Common Cause of Persistent Infections
10.1126/science.284.5418.1318 · 1999 · External reference
Bacterial biofilms: From the natural environment to infectious diseases
10.1038/nrmicro821 · 2004 · External reference
Antibiotic resistance of bacteria in biofilms
10.1016/s0140-6736(01)05321-1 · 2001 · External reference
Treatment of Infections Associated with Surgical Implants
10.1056/nejmra035415 · 2004 · External reference
10.3390/antibiotics12010012
10.3390/antibiotics12010012 · External reference
Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies
10.1128/mmbr.00026-19 · 2020 · External reference
The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation
10.1128/iai.67.10.5427-5433.1999 · 1999 · External reference
Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis
10.1111/j.1365-2958.1996.tb02548.x · 1996 · External reference
10.1371/journal.ppat.1000052
10.1371/journal.ppat.1000052 · External reference
Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus
10.1046/j.1365-2958.2003.03599.x · 2003 · External reference
SarA and not σB is essential for biofilm development by Staphylococcus aureus
10.1046/j.1365-2958.2003.03493.x · 2003 · External reference
The biofilm matrix
10.1038/nrmicro2415 · 2010 · External reference
Persister cells, dormancy and infectious disease
10.1038/nrmicro1557 · 2006 · External reference
Mechanisms of antibiotic resistance in bacterial biofilms
10.1078/1438-4221-00196 · 2002 · External reference
Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials
10.1016/j.biomaterials.2012.05.031 · 2012 · External reference
Incidence of biofilm formation among MRSA and MSSA clinical isolates from hospitalized patients in Israel
10.1111/jam.15612 · 2022 · External reference
10.3389/fcimb.2015.00001
10.3389/fcimb.2015.00001 · External reference
Biofilm formation by Scottish clinical isolates of Staphylococcus aureus
10.1099/jmm.0.2008/000968-0 · 2008 · External reference
Study on biofilm-forming properties of clinical isolates of Staphylococcus aureus
10.3855/jidc.1743 · 2011 · External reference
Isolation and Characterization of Biofilm Formation-Defective Mutants of Staphylococcus aureus
10.1128/iai.01143-06 · 2007 · External reference
Assessment of the biofilm formation capacities of Staphylococcus aureus strains Newman and Newman D2C in vitro and in vivo
10.1038/s41598-025-00521-5 · 2025 · External reference
Dysfunctional accessory gene regulator (agr) as a prognostic factor in invasive Staphylococcus aureus infection: A systematic review and meta-analysis
2020 · External reference
10.1007/s10096-017-3044-2
10.1007/s10096-017-3044-2 · External reference
A review of the biomaterials technologies for infection-resistant surfaces
10.1016/j.biomaterials.2013.07.089 · 2013 · External reference
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
10.3390/polym3031377 · 2011 · External reference
Infections associated with cardiac electronic implantable devices: Economic perspectives and impact of the TYRX™ antibacterial envelope
2021 · External reference
Microbiological effects of sublethal levels of antibiotics
10.1038/nrmicro3270 · 2014 · External reference
Antibiotic-Induced Biofilm Formation
10.5301/ijao.5000027 · 2011 · External reference
Enhanced Biofilm Formation by Tetracycline in a Staphylococcus aureus Naturally Lacking ica Operon and atl
10.1089/mdr.2023.0186 · 2024 · External reference
Sub-Inhibitory Concentrations of Rifampicin Strongly Stimulated Biofilm Production in S. aureus
10.2174/1874285801711010142 · 2017 · External reference
Low Levels of β-Lactam Antibiotics Induce Extracellular DNA Release and Biofilm Formation in Staphylococcus aureus
10.1128/mbio.00198-12 · 2012 · External reference
Effects of Low-Dose Amoxicillin on Staphylococcus aureus USA300 Biofilms
10.1128/aac.02070-15 · 2016 · External reference
Modulation of Staphylococcus aureus Biofilm Matrix by Subinhibitory Concentrations of Clindamycin
10.1128/aac.00463-16 · 2016 · External reference
Extended duration dosing and distribution of dalbavancin into bone and articular tissue
10.1128/aac.04550-14 · 2015 · External reference
Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
10.1007/s10096-016-2845-z · 2016 · External reference
Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates
10.1016/j.diagmicrobio.2003.09.004 · 2004 · External reference
Origin, structure, and activity in vitro and in vivo of dalbavancin
10.1093/jac/dki005 · 2005 · External reference
In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections
10.1016/j.diagmicrobio.2016.05.009 · 2016 · External reference
In vitro additive effects of dalbavancin and rifampicin against biofilm of Staphylococcus aureus
10.1038/s41598-021-02709-x · 2021 · External reference
Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis
10.1093/jac/dkv357 · 2015 · External reference
10.3389/fbioe.2022.1021827
10.3389/fbioe.2022.1021827 · External reference
Unresolved reference
External reference
Static Biofilm Cultures of Gram-Positive Pathogens Grown in a Microtiter Format Used for Anti-Biofilm Drug Discovery
10.1002/0471141755.ph13a08s50 · 2010 · External reference
Structure-preserving fixation allows scanning electron microscopy to reveal biofilm microstructure and interactions with immune cells
10.1111/jmi.13252 · 2023 · External reference
Optimization of the RNeasy Mini Kit to obtain high-quality total RNA from sessile cells of Staphylococcus aureus
10.1590/1414-431x20154734 · 2015 · External reference
Factors Influencing Broth Microdilution Antimicrobial Susceptibility Test Results for Dalbavancin, a New Glycopeptide Agent
10.1128/jcm.02411-06 · 2007 · External reference
Induction of MRSA Biofilm by Low-Dose β-Lactam Antibiotics: Specificity, Prevalence and Dose-Response Effects
2013 · External reference
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
10.1128/mmbr.65.2.232-260.2001 · 2001 · External reference
10.3389/fcimb.2014.00171
10.3389/fcimb.2014.00171 · External reference
Efficacy of Daptomycin in Implant-Associated Infection Due to Methicillin-Resistant Staphylococcus aureus: Importance of Combination with Rifampin
10.1128/aac.00047-09 · 2009 · External reference
Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus
10.1136/jcp.34.5.559 · 1981 · External reference
10.1128/aac.01746-18
10.1128/aac.01746-18 · External reference
Differential Gene Expression Profiling of Staphylococcus aureus Cultivated under Biofilm and Planktonic Conditions
10.1128/aem.71.5.2663-2676.2005 · 2005 · External reference
Effect of Subinhibitory Antibiotic Concentrations on Polysaccharide Intercellular Adhesin Expression in Biofilm-Forming Staphylococcus epidermidis
10.1128/aac.44.12.3357-3363.2000 · 2000 · External reference
Enhancement of Biofilm Formation by Subinhibitory Concentrations of Macrolides in icaADBC- Positive and -Negative Clinical Isolates of Staphylococcus epidermidis
10.1128/aac.01565-09 · 2010 · External reference
Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus
10.1002/jobm.201000221 · 2010 · External reference
Modulation of virulence gene expression by cell wall active antibiotics in Staphylococcus aureus
10.1093/jac/dkr043 · 2011 · External reference
10.3389/fmicb.2021.603151
10.3389/fmicb.2021.603151 · External reference
How Staphylococcus aureus biofilms develop their characteristic structure
10.1073/pnas.1115006109 · 2012 · External reference
10.3390/pathogens10111385
10.3390/pathogens10111385 · External reference
10.1128/iai.00859-19
10.1128/iai.00859-19 · External reference
Mimicking critical environment factors for a static in vitro biofilm formation model on blood-contact implant materials
2022 · External reference
10.3389/fmicb.2019.01626
10.3389/fmicb.2019.01626 · External reference
Static Biofilm Cultures of Gram-Positive Pathogens Grown in a Microtiter Format Used for Anti-Biofilm Drug Discovery
10.1002/0471141755.ph13a08s50 · ExternalCitation · doi-reference
Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus
10.1002/jobm.201000221 · ExternalCitation · doi-reference
Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
10.1007/s10096-016-2845-z · ExternalCitation · doi-reference
10.1007/s10096-017-3044-2
10.1007/s10096-017-3044-2 · ExternalCitation · doi-reference
Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials
10.1016/j.biomaterials.2012.05.031 · ExternalCitation · doi-reference
A review of the biomaterials technologies for infection-resistant surfaces
10.1016/j.biomaterials.2013.07.089 · ExternalCitation · doi-reference
Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates
10.1016/j.diagmicrobio.2003.09.004 · ExternalCitation · doi-reference
In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections
10.1016/j.diagmicrobio.2016.05.009 · ExternalCitation · doi-reference
Management and Outcome of Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infections
10.1016/j.jacc.2007.01.072 · ExternalCitation · doi-reference
Early onset prosthetic hip and knee joint infection: Treatment and outcomes in Victoria, Australia
10.1016/j.jhin.2012.09.005 · ExternalCitation · doi-reference
Antibiotic resistance of bacteria in biofilms
10.1016/s0140-6736(01)05321-1 · ExternalCitation · doi-reference
Persister cells, dormancy and infectious disease
10.1038/nrmicro1557 · ExternalCitation · doi-reference
The biofilm matrix
10.1038/nrmicro2415 · ExternalCitation · doi-reference
Microbiological effects of sublethal levels of antibiotics
10.1038/nrmicro3270 · ExternalCitation · doi-reference
Bacterial biofilms: From the natural environment to infectious diseases
10.1038/nrmicro821 · ExternalCitation · doi-reference
In vitro additive effects of dalbavancin and rifampicin against biofilm of Staphylococcus aureus
10.1038/s41598-021-02709-x · ExternalCitation · doi-reference
Assessment of the biofilm formation capacities of Staphylococcus aureus strains Newman and Newman D2C in vitro and in vivo
10.1038/s41598-025-00521-5 · ExternalCitation · doi-reference
SarA and not σB is essential for biofilm development by Staphylococcus aureus
10.1046/j.1365-2958.2003.03493.x · ExternalCitation · doi-reference
Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus
10.1046/j.1365-2958.2003.03599.x · ExternalCitation · doi-reference
Treatment of Infections Associated with Surgical Implants
10.1056/nejmra035415 · ExternalCitation · doi-reference
How Staphylococcus aureus biofilms develop their characteristic structure
10.1073/pnas.1115006109 · ExternalCitation · doi-reference
Mechanisms of antibiotic resistance in bacterial biofilms
10.1078/1438-4221-00196 · ExternalCitation · doi-reference
Enhanced Biofilm Formation by Tetracycline in a Staphylococcus aureus Naturally Lacking ica Operon and atl
10.1089/mdr.2023.0186 · ExternalCitation · doi-reference
Origin, structure, and activity in vitro and in vivo of dalbavancin
10.1093/jac/dki005 · ExternalCitation · doi-reference
Modulation of virulence gene expression by cell wall active antibiotics in Staphylococcus aureus
10.1093/jac/dkr043 · ExternalCitation · doi-reference
Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis
10.1093/jac/dkv357 · ExternalCitation · doi-reference
Biofilm formation by Scottish clinical isolates of Staphylococcus aureus
10.1099/jmm.0.2008/000968-0 · ExternalCitation · doi-reference
Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis
10.1111/j.1365-2958.1996.tb02548.x · ExternalCitation · doi-reference
Incidence of biofilm formation among MRSA and MSSA clinical isolates from hospitalized patients in Israel
10.1111/jam.15612 · ExternalCitation · doi-reference
Structure-preserving fixation allows scanning electron microscopy to reveal biofilm microstructure and interactions with immune cells
10.1111/jmi.13252 · ExternalCitation · doi-reference
Bacterial Biofilms: A Common Cause of Persistent Infections
10.1126/science.284.5418.1318 · ExternalCitation · doi-reference
Efficacy of Daptomycin in Implant-Associated Infection Due to Methicillin-Resistant Staphylococcus aureus: Importance of Combination with Rifampin
10.1128/aac.00047-09 · ExternalCitation · doi-reference
Modulation of Staphylococcus aureus Biofilm Matrix by Subinhibitory Concentrations of Clindamycin
10.1128/aac.00463-16 · ExternalCitation · doi-reference
Enhancement of Biofilm Formation by Subinhibitory Concentrations of Macrolides in icaADBC- Positive and -Negative Clinical Isolates of Staphylococcus epidermidis
10.1128/aac.01565-09 · ExternalCitation · doi-reference
10.1128/aac.01746-18
10.1128/aac.01746-18 · ExternalCitation · doi-reference
Effects of Low-Dose Amoxicillin on Staphylococcus aureus USA300 Biofilms
10.1128/aac.02070-15 · ExternalCitation · doi-reference
Extended duration dosing and distribution of dalbavancin into bone and articular tissue
10.1128/aac.04550-14 · ExternalCitation · doi-reference
Effect of Subinhibitory Antibiotic Concentrations on Polysaccharide Intercellular Adhesin Expression in Biofilm-Forming Staphylococcus epidermidis
10.1128/aac.44.12.3357-3363.2000 · ExternalCitation · doi-reference
Differential Gene Expression Profiling of Staphylococcus aureus Cultivated under Biofilm and Planktonic Conditions
10.1128/aem.71.5.2663-2676.2005 · ExternalCitation · doi-reference
Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management
10.1128/cmr.00134-14 · ExternalCitation · doi-reference
10.1128/iai.00859-19
10.1128/iai.00859-19 · ExternalCitation · doi-reference
Isolation and Characterization of Biofilm Formation-Defective Mutants of Staphylococcus aureus
10.1128/iai.01143-06 · ExternalCitation · doi-reference
The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation
10.1128/iai.67.10.5427-5433.1999 · ExternalCitation · doi-reference
Factors Influencing Broth Microdilution Antimicrobial Susceptibility Test Results for Dalbavancin, a New Glycopeptide Agent
10.1128/jcm.02411-06 · ExternalCitation · doi-reference
Low Levels of β-Lactam Antibiotics Induce Extracellular DNA Release and Biofilm Formation in Staphylococcus aureus
10.1128/mbio.00198-12 · ExternalCitation · doi-reference
Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies
10.1128/mmbr.00026-19 · ExternalCitation · doi-reference
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
10.1128/mmbr.65.2.232-260.2001 · ExternalCitation · doi-reference
Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus
10.1136/jcp.34.5.559 · ExternalCitation · doi-reference
10.1371/journal.ppat.1000052
10.1371/journal.ppat.1000052 · ExternalCitation · doi-reference
Optimization of the RNeasy Mini Kit to obtain high-quality total RNA from sessile cells of Staphylococcus aureus
10.1590/1414-431x20154734 · ExternalCitation · doi-reference
Sub-Inhibitory Concentrations of Rifampicin Strongly Stimulated Biofilm Production in S. aureus
10.2174/1874285801711010142 · ExternalCitation · doi-reference
10.3389/fbioe.2022.1021827
10.3389/fbioe.2022.1021827 · ExternalCitation · doi-reference
10.3389/fcimb.2014.00171
10.3389/fcimb.2014.00171 · ExternalCitation · doi-reference
10.3389/fcimb.2015.00001
10.3389/fcimb.2015.00001 · ExternalCitation · doi-reference
10.3389/fmicb.2019.01626
10.3389/fmicb.2019.01626 · ExternalCitation · doi-reference
10.3389/fmicb.2021.603151
10.3389/fmicb.2021.603151 · ExternalCitation · doi-reference
10.3390/antibiotics12010012
10.3390/antibiotics12010012 · ExternalCitation · doi-reference
10.3390/pathogens10111385
10.3390/pathogens10111385 · ExternalCitation · doi-reference
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
10.3390/polym3031377 · ExternalCitation · doi-reference
Study on biofilm-forming properties of clinical isolates of Staphylococcus aureus
10.3855/jidc.1743 · ExternalCitation · doi-reference
Antibiotic-Induced Biofilm Formation
10.5301/ijao.5000027 · ExternalCitation · doi-reference
